Abstract
Fifteen patients with confirmed psoriatic arthritis were treated with recombinant interferon-gamma (IFN-gamma) between October 1985 and February 1986. In ten patients a marked relief of joint pain was achieved within 28 days. Daily doses of less than 200 micrograms IFN-gamma did not have any effect on the skin lesions. Tolerance of the drug, given subcutaneously, was dose-dependent, no side-effects occurred with dosages of less than 100 micrograms/d.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.